Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
Abbott India warns of laxatives shortage in tussle with Goa regulatorAbbott Laboratories' Indian unit has warned of potential supply shortages of two popular laxative syrups, Cremaffin and Duphalac, after pro...
Why Nithya Balasubramanian is betting on Sun Pharma & Cipla, avoiding 2 others“When it comes to pharma we are not seeing secular growth. While India can be a secular growth story, we believe the US would not be and th...